Ucsf Fresno

Fresno, California 93721

2 studies enrolling now · 31 studies all time

What they study most

ARDS, Acute Respiratory Distress Syndrome, Acute Respiratory Infection, B Cell Lymphoma, Birth Defect, Brain Infarction, COVID-19, Cerebral Ischemia, Cerebral Palsy, Chronic Hepatitis C, Chronic Limb-Threatening Ischemia, Chronic Liver Disease

Studies at this site

• A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) — Recruiting now
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) — Running, not enrolling
• Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System — Completed
• Pulmonary Function by Litter Position — Enrolling by invitation
• Esprit BTK Post-Approval Study — Running, not enrolling
• LIFE-BTK Randomized Controlled Trial — Running, not enrolling
• Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD) — Completed
• A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. — Completed
• A Study to Investigate Leramistat in Patients With IPF — Withdrawn before enrolling
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection — Stopped early
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19 — Paused
• Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery — Completed
• Backpack Weight Impacts — Completed
• Clinical Utility of Pediatric Whole Exome Sequencing — Completed
• Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis — Completed
• Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a — Completed
• COVID-19 in Patients With Chronic Liver Diseases — Completed
• Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease — Completed
• Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? — Completed
• A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label — Stopped early
• Insulin Resistance Intervention After Stroke Trial — Completed
• Vitamin D to Improve Outcomes by Leveraging Early Treatment — Completed
• Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis — Stopped early
• Reevaluation Of Systemic Early Neuromuscular Blockade — Completed
• Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument — Completed
• Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus — Withdrawn before enrolling
• A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study — Completed
• " Patients Attitude Towards Physicians and Health Screening Issues Among First Generation Asian-Indian Immigrants to United States". — Stopped early
• Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients — Completed
• EASE Trial: Exhale Airway Stents for Emphysema — Status unconfirmed
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early